- Home
- BRNS vs ARQQ Comparison
BRNS vs ARQQ Comparison
Compare BRNS & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- ARQQ
- Stock Information
- Founded
- BRNS 2016
- ARQQ 2017
- Country
- BRNS United Kingdom
- ARQQ United Kingdom
- Employees
- BRNS N/A
- ARQQ N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- ARQQ Computer Software: Prepackaged Software
- Sector
- BRNS Health Care
- ARQQ Technology
- Exchange
- BRNS Nasdaq
- ARQQ Nasdaq
- Market Cap
- BRNS 36.0M
- ARQQ 531.6M
- IPO Year
- BRNS 2021
- ARQQ N/A
- Fundamental
- Price
- BRNS $1.02
- ARQQ $36.54
- Analyst Decision
- BRNS Strong Buy
- ARQQ Strong Buy
- Analyst Count
- BRNS 1
- ARQQ 1
- Target Price
- BRNS $3.00
- ARQQ $52.00
- AVG Volume (30 Days)
- BRNS 18.3K
- ARQQ 1.3M
- Earning Date
- BRNS 08-07-2025
- ARQQ 05-22-2025
- Dividend Yield
- BRNS N/A
- ARQQ N/A
- EPS Growth
- BRNS N/A
- ARQQ N/A
- EPS
- BRNS N/A
- ARQQ 0.48
- Revenue
- BRNS $14,969,000.00
- ARQQ $241,000.00
- Revenue This Year
- BRNS N/A
- ARQQ $1,818.77
- Revenue Next Year
- BRNS N/A
- ARQQ N/A
- P/E Ratio
- BRNS N/A
- ARQQ $75.25
- Revenue Growth
- BRNS 4381.74
- ARQQ N/A
- 52 Week Low
- BRNS $0.64
- ARQQ $3.72
- 52 Week High
- BRNS $1.58
- ARQQ $52.79
- Technical
- Relative Strength Index (RSI)
- BRNS 57.82
- ARQQ 55.94
- Support Level
- BRNS $0.90
- ARQQ $34.50
- Resistance Level
- BRNS $1.10
- ARQQ $41.40
- Average True Range (ATR)
- BRNS 0.06
- ARQQ 3.86
- MACD
- BRNS 0.01
- ARQQ -0.62
- Stochastic Oscillator
- BRNS 65.52
- ARQQ 37.75
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.